alpha-1 antitrypsin Archives - Medical Conferences

Alvelestat for AATD meets primary endpoints in phase 2 trial

Presented By

Prof. Robert Stockley, University Hospital Birmingham, UK

Trial

Phase 2, ASTRAEUS

Conference

ATS 2023

Type

News article

12 June 2023 16:08

New AATD therapy may alleviate treatment burden for patients

Presented By

Dr Brooks Kuhn, UC Davis School of Medicine, CA, USA

Trial

Phase 1

Conference

ATS 2023

Type

News article

12 June 2023 16:02

Alpha-1 antitrypsin for ARDS secondary to severe COVID-19

Presented By

Dr Oliver McElvaney, Royal College of Surgeons, Ireland

Trial

Phase 2

Conference

ATS 2022

Type

Peer-reviewed article

18 July 2022 13:53

site created by:

© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy

HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com